Comphya is a series a startup based in Switzerland. 1 investor tracked.
Based in Switzerland, Comphya is a startup founded in 2025. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Comphya is a medical device company developing a novel implantable device to restore erectile function in patients non-responsive to current treatments such as PDE5 inhibitors (e.g. Viagra, Cialis) or penile injections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.